Neville Rodie & Shaw Inc. decreased its holdings in Colgate-Palmolive Company (NYSE:CL) by 5.8% in the second quarter, according to its most recent 13F filing with the SEC. The institutional investor owned 24,570 shares of the company’s stock after selling 1,525 shares during the period. Neville Rodie & Shaw Inc.’s holdings in Colgate-Palmolive were worth $1,822,000 as of its most recent SEC filing.
Other institutional investors have also made changes to their positions in the company. Chickasaw Capital Management LLC boosted its stake in shares of Colgate-Palmolive by 218.3% in the 1st quarter. Chickasaw Capital Management LLC now owns 16,920 shares of the company’s stock valued at $1,238,000 after purchasing an additional 11,605 shares in the last quarter. Meritage Portfolio Management boosted its stake in shares of Colgate-Palmolive by 0.3% in the 1st quarter. Meritage Portfolio Management now owns 95,879 shares of the company’s stock valued at $7,017,000 after purchasing an additional 255 shares in the last quarter. Alliancebernstein L.P. boosted its stake in shares of Colgate-Palmolive by 4.2% in the 1st quarter. Alliancebernstein L.P. now owns 1,899,356 shares of the company’s stock valued at $139,014,000 after purchasing an additional 77,414 shares in the last quarter. Israel Discount Bank of New York purchased a new stake in shares of Colgate-Palmolive in the 1st quarter valued at $1,349,000. Finally, Principal Financial Group Inc. boosted its stake in shares of Colgate-Palmolive by 0.6% in the 1st quarter. Principal Financial Group Inc. now owns 1,271,008 shares of the company’s stock valued at $93,025,000 after purchasing an additional 7,905 shares in the last quarter. 73.16% of the stock is owned by institutional investors.
ILLEGAL ACTIVITY WARNING: This piece was originally published by Transcript Daily and is the property of of Transcript Daily. If you are viewing this piece on another publication, it was illegally copied and republished in violation of international copyright law. The legal version of this piece can be viewed at https://transcriptdaily.com/2017/09/17/neville-rodie-shaw-inc-cuts-stake-in-colgate-palmolive-company-cl.html.
CL has been the subject of a number of research reports. Royal Bank Of Canada reaffirmed a “hold” rating and issued a $74.00 price objective on shares of Colgate-Palmolive in a research note on Thursday, May 25th. Bank of America Corporation upped their price objective on shares of Colgate-Palmolive from $78.00 to $80.00 and gave the company a “buy” rating in a research note on Wednesday, May 31st. BidaskClub cut shares of Colgate-Palmolive from a “hold” rating to a “sell” rating in a research note on Saturday, June 24th. Zacks Investment Research raised shares of Colgate-Palmolive from a “hold” rating to a “buy” rating and set a $83.00 price objective for the company in a research note on Tuesday, July 4th. Finally, Jefferies Group LLC upped their price objective on shares of Colgate-Palmolive from $76.00 to $77.00 and gave the company a “hold” rating in a research note on Thursday, July 6th. Two equities research analysts have rated the stock with a sell rating, thirteen have given a hold rating and two have assigned a buy rating to the company. The company presently has a consensus rating of “Hold” and an average price target of $75.83.
In other news, Vice Chairman Franck J. Moison sold 35,000 shares of the business’s stock in a transaction on Monday, August 7th. The shares were sold at an average price of $71.52, for a total transaction of $2,503,200.00. Following the completion of the sale, the insider now directly owns 201,411 shares of the company’s stock, valued at $14,404,914.72. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which can be accessed through the SEC website. Also, SVP John J. Huston sold 14,000 shares of the business’s stock in a transaction on Thursday, August 10th. The shares were sold at an average price of $71.36, for a total transaction of $999,040.00. Following the sale, the senior vice president now directly owns 88,598 shares of the company’s stock, valued at $6,322,353.28. The disclosure for this sale can be found here. Insiders have sold 217,969 shares of company stock valued at $15,693,933 over the last ninety days. 1.02% of the stock is owned by insiders.
Shares of Colgate-Palmolive Company (NYSE CL) traded up 0.19% on Friday, reaching $72.28. 4,662,365 shares of the company’s stock traded hands. The firm has a market cap of $63.67 billion, a P/E ratio of 26.86 and a beta of 0.80. Colgate-Palmolive Company has a 12-month low of $63.43 and a 12-month high of $77.27. The stock has a 50-day moving average of $71.57 and a 200 day moving average of $73.28.
Colgate-Palmolive (NYSE:CL) last posted its quarterly earnings data on Friday, July 21st. The company reported $0.72 EPS for the quarter, hitting the consensus estimate of $0.72. The company had revenue of $3.83 billion during the quarter, compared to analyst estimates of $3.89 billion. Colgate-Palmolive had a net margin of 15.83% and a return on equity of 3,121.95%. Colgate-Palmolive’s quarterly revenue was down .5% compared to the same quarter last year. During the same period in the previous year, the firm earned $0.70 earnings per share. On average, equities research analysts expect that Colgate-Palmolive Company will post $2.89 earnings per share for the current year.
Colgate-Palmolive Company Profile
Colgate-Palmolive Company (Colgate) is a consumer products company. The Company operates in two product segments: Oral, Personal and Home Care, and Pet Nutrition. The Oral, Personal and Home Care product segment is operated through five geographic segments, which include North America, Latin America, Europe, Asia Pacific and Africa/Eurasia.
Receive News & Ratings for Colgate-Palmolive Company Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Colgate-Palmolive Company and related companies with MarketBeat.com's FREE daily email newsletter.